Emmanuel J. Simons
Chief Executive Officer bei AKOUOS
Profil
Emmanuel J.
Simons is the founder.
He founded Akouos, Inc. in 2016 and currently holds the title of Chief Executive Officer.
Dr. Simons has a doctorate degree from Massachusetts Institute of Technology, an MBA from Harvard Business School, and an undergraduate degree from Harvard College.
Aktive Positionen von Emmanuel J. Simons
| Unternehmen | Position | Beginn |
|---|---|---|
| AKOUOS | Chief Executive Officer | 01.01.2016 |
Ausbildung von Emmanuel J. Simons
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
